International Journal of Radiation Oncology*Biology*Physics
Physics ContributionCombined Photon and Electron Three-Dimensional Conformal Versus Intensity-Modulated Radiotherapy With Integrated Boost for Adjuvant Treatment of Malignant Pleural Mesothelioma After Pleuropneumonectomy
Introduction
The role of radiotherapy (RT) for palliative treatment of malignant pleural mesothelioma (MPM) is well established 1, 2. RT is effective for pain control in the case of thoracic wall invasion and is used for the prevention of malignant seeding after invasive procedures 3, 4. The role of RT within the setting of radical multimodal therapy is less well defined, although the thoracic relapse rates after extrapleural pleuropneumonectomy (EPP) of MPM are high and adjuvant treatment is warranted. In recent years, adjuvant RT has been advocated as a part of postoperative therapy, and various techniques with different field geometries and dose schedules have been used 5, 6. More recently, neoadjuvant therapy with preoperative chemotherapy has been added to the treatment concept and has shown promising results in specialized institutions (7).
The best-documented multimodal potentially curative approach to MPM is pleuropneumonectomy, combined with chemotherapy and RT (trimodality approach) in selected patients with early disease stages. The survival rate of a large series of 176 patients after surgery was 38% at 2 years and 15% at 5 years, with a median survival of 19 months (5). More recently, preoperative chemotherapy followed by EPP has been investigated, and its feasibility has been reported in a multicenter trial 7, 8. The benefit of preoperative chemotherapy, however, will remain difficult to prove unless randomized trials are initiated. In some cases, operable disease might progress during chemotherapy, rendering subsequent resection more difficult. In our experience, the overall treatment time resulting from combined chemotherapy followed by surgery and the protracted therapy-associated stress on patients have made postoperative RT potentially more difficult and more challenging (9). The radiation oncologist has to decide whether full coverage of the hemithorax can be proposed or a treatment volume limited to the initial tumor region is sufficient and feasible after chemotherapy and EPP in each case. There is little doubt that preoperative chemotherapy can jeopardize the benefits from RT because of cumulative toxicity and treatment-related asthenia. Furthermore, no standard for either chemotherapy or RT exists. In particular, the acceptable size of the target volumes, dose constraints, and radiation techniques should be considered before implementation of RT in multimodal settings.
We evaluated two RT techniques that were used in our center for the purpose of RT after chemotherapy and surgery for MPM: three-dimensional (3D) conformal RT (3D-CRT), used until 2004, and intensity-modulated RT (IMRT). With both planning techniques, the entire ipsilateral hemithorax was defined as the clinical target volume (CTV2), with a high-risk area represented by the macroscopically resected tumor (CTV1).
Section snippets
Methods and Materials
For this retrospective treatment planning study, we reviewed the clinical records of all patients (n = 17) diagnosed with MPM between 2000 and 2006 who were treated with chemotherapy followed by EPP and RT. All patients had presented with Stage cT1-T3N0-N1M0. Mediastinal staging was done using computed tomography (CT) and positron emission tomography/CT. Mediastinoscopy was performed in all patients to exclude mediastinal involvement; patients with mediastinal involvement did not qualify for
Results
The percentage of the PTVs receiving <95% and the percentage receiving >105% of the prescribed dose were assessed for 3D-CRT and IMRT. The mean dose for all structures was assessed. The percentage of the kidney (or heart) receiving >15 Gy (or 45 Gy), the percentage of the lung receiving >13 and 20 Gy, and the maximal dose to the spinal cord were evaluated (Table 2). The reported values were averaged for the 17 MPM patients from the present study. Dose delivery to the PTV was improved using
Discussion
Continuously improving technology have led to improved dose conformity and increasing interest in integrating RT in the treatment concepts of MPM 13, 14. Because IMRT is an optimal technical approach for treating concave regions with many critical and radiation-sensitive tissue structures in close proximity to the targeted region, it seems especially well suited for the treatment of MPM, especially because greater conformity has the potential to improve the effect of RT (15). However, more
Conclusion
Both 3D-CRT and IMRT might be adequate techniques for the treatment of MPM. In the present study, 3D-CRT and IMRT were both able to keep the maximal and mean doses in the OARs to less than the reported critical levels. However, after preoperative chemotherapy and EPP, the dose constraints must be reduced to respect the specific case. An individualized use of techniques respecting patient- and disease-specific features is the key for optimal use of RT. Still, IMRT seems to be the superior
References (21)
- et al.
Radiotherapy for mesothelioma
Hematol Oncol Clin North Am
(2005) - et al.
The role of radiation therapy in thoracic tumors
Hematol Oncol Clin North Am
(2006) - et al.
Factors influencing the outcome of radiotherapy in malignant mesothelioma of the pleura—A single-institution experience with 189 patients
Int J Radiat Oncol Biol Phys
(1999) - et al.
Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma: A randomized trial of local radiotherapy
Chest
(1995) - et al.
Resection margins, extrapleural nodal status, and cell type determine postoperative long-term survival in trimodality therapy of malignant pleural mesothelioma: Results in 183 patients
J Thorac Cardiovasc Surg
(1999) - et al.
Hemithoracic radiation after extrapleural pneumonectomy for malignant pleural mesothelioma
Int J Radiat Oncol Biol Phys
(2003) - et al.
Hemithoracic radiation therapy after pleurectomy/decortication for malignant pleural mesothelioma
Int J Radiat Oncol Biol Phys
(2005) - et al.
Technique for external beam treatment for mesothelioma
Int J Radiat Oncol Biol Phys
(1987) - et al.
Treatment planning system evaluation for mesothelioma IMRT
Lung Cancer
(2005) - et al.
Inverse planned stereotactic intensity modulated radiotherapy (IMRT) in the palliative treatment of malignant mesothelioma of the pleura: The Heidelberg experience
Lung Cancer
(2005)
Cited by (0)
Supported by the Radium Fund, University of Zurich, Switzerland to I. F. Ciernik.
Conflict of interest: none.